SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-043510
Filing Date
2021-02-16
Accepted
2021-02-16 08:15:54
Documents
15
Period of Report
2021-02-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d58289d8k.htm   iXBRL 8-K 26282
2 EX-99.1 d58289dex991.htm EX-99.1 12150
6 GRAPHIC g58289g0216021605347.jpg GRAPHIC 3142
7 GRAPHIC g58289g0216024439706.jpg GRAPHIC 5478
  Complete submission text file 0001193125-21-043510.txt   180333

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vivo-20210216.xsd EX-101.SCH 3099
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vivo-20210216_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vivo-20210216_pre.xml EX-101.PRE 10972
8 EXTRACTED XBRL INSTANCE DOCUMENT d58289d8k_htm.xml XML 3272
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-14902 | Film No.: 21632712
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences